{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:33:38Z","timestamp":1786448018278,"version":"build-2736575974"},"reference-count":40,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Commission","doi-asserted-by":"publisher","award":["JCYJ20230807113003006"],"award-info":[{"award-number":["JCYJ20230807113003006"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"award":["JCYJ20230807113003006"],"award-info":[{"award-number":["JCYJ20230807113003006"]}],"id":[{"id":"https:\/\/ror.org\/017n8df75","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background\/Objectives: Psoriatic arthritis (PsA) affects up to 30% of psoriasis patients but remains underdiagnosed due to heterogeneous early manifestations. Existing tools rely on advanced imaging or biomarkers, limiting feasibility. This study aimed to develop a simple nomogram, using routinely available clinical features to identify patients with likely PsA. Methods: This multicenter cross-sectional study enrolled adult psoriasis patients from two tertiary hospitals (training: n = 884; validation: n = 690). PsA was diagnosed using the Classification Criteria for Psoriatic Arthritis (CASPAR) by rheumatologists and dermatologists who were blinded to each other\u2019s assessments. Thirteen candidate predictors, including demographics, disease history, and lesion characteristics, were prespecified. Independent predictors were selected using least absolute shrinkage and selection operator (LASSO) regression, followed by multivariable logistic regression. Internal validation used 1000 bootstrap resamples, followed by temporal\u2013geographic validation. Performance was assessed using area under the curve (AUC), calibration plots, the Hosmer\u2013Lemeshow test, decision curve analysis (DCA), and clinical impact curves (CIC). Sensitivity analyses included E-value analysis for unmeasured confounding and alternative model specifications. Results: Five independent predictors were identified: uveitis (odds ratio (OR): 5.23, 95% confidence interval (CI): 1.94\u201314.10), inverse lesions (OR: 1.65, 95% CI: 1.09\u20132.48), scalp lesions (OR: 2.97, 95% CI: 1.45\u20136.10), nail lesions (OR: 5.98, 95% CI: 3.69\u20139.68), and arthralgia (OR: 20.23, 95% CI: 13.14\u201331.13). The nomogram showed good discrimination (AUC: 0.885 training, 0.874 validation), with good calibration and clinical utility confirmed by DCA and CIC. Conclusions: This nomogram, integrating five clinically accessible predictors, offers a practical tool to identify psoriasis patients with likely PsA, supporting timely referral in tertiary dermatology outpatient settings.<\/jats:p>","DOI":"10.3390\/jcm15166215","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T10:32:16Z","timestamp":1786444336000},"page":"6215","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Clinically Accessible Nomogram for Identifying Likely Psoriatic Arthritis Among Patients with Psoriasis: A Multicenter Cross-Sectional Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1720-1237","authenticated-orcid":false,"given":"Qing","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Dermatology, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Luan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6477-2283","authenticated-orcid":false,"given":"Mouhsun","family":"Chiang","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Min","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41572-021-00293-y","article-title":"Psoriatic arthritis","volume":"7","author":"FitzGerald","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/rheumatology\/keab522","article-title":"Risk of major adverse cardiovascular events in patients initiating biologics\/apremilast for psoriatic arthritis: A nationwide cohort study","volume":"61","author":"Penso","year":"2022","journal-title":"Rheumatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2147\/PTT.S471707","article-title":"Metabolic Syndrome in Psoriasis and Psoriatic Arthritis in a Mixed Race Population: Comparison of Their Prevalences","volume":"14","author":"Acioly","year":"2024","journal-title":"Psoriasis"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/jdv.19192","article-title":"Depression, a major comorbidity of psoriatic disease, is caused by metabolic inflammation","volume":"37","author":"Mrowietz","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e081860","DOI":"10.1136\/bmj-2024-081860","article-title":"Advances in the management of psoriatic arthritis in adults","volume":"387","author":"Kharouf","year":"2024","journal-title":"BMJ"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jaad.2024.03.059","article-title":"Psoriatic arthritis: A comprehensive review for the dermatologist part I: Epidemiology, comorbidities, pathogenesis, and diagnosis","volume":"92","author":"Elman","year":"2025","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"108390","DOI":"10.1016\/j.clim.2020.108390","article-title":"Challenges in the clinical diagnosis of psoriatic arthritis","volume":"214","author":"Rida","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/art.24172","article-title":"Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: A population-based study","volume":"61","author":"Wilson","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/art.39494","article-title":"The Incidence and Risk Factors for Psoriatic Arthritis in Patients with Psoriasis: A Prospective Cohort Study","volume":"68","author":"Eder","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41584-021-00578-2","article-title":"Consensus terminology for preclinical phases of psoriatic arthritis for use in research studies: Results from a Delphi consensus study","volume":"17","author":"Haberman","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/annrheumdis-2011-200416","article-title":"Smoking and risk of incident psoriatic arthritis in US women","volume":"71","author":"Li","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/annrheumdis-2012-201299","article-title":"Obesity and the risk of psoriatic arthritis: A population-based study","volume":"71","author":"Love","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jaad.2007.04.001","article-title":"The PASE questionnaire: Pilot-testing a psoriatic arthritis screening and evaluation tool","volume":"57","author":"Husni","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/ard.2008.089441","article-title":"Development and initial validation of a screening questionnaire for psoriatic arthritis: The Toronto Psoriatic Arthritis Screen (ToPAS)","volume":"68","author":"Gladman","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/rheumatology\/key314","article-title":"Psoriatic arthritis screening: A systematic review and meta-analysis","volume":"58","author":"Iragorri","year":"2019","journal-title":"Rheumatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: Development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10067-024-07244-4","article-title":"Risk prediction model for psoriatic arthritis: NHANES data and multi-algorithm approach","volume":"44","author":"Zhan","year":"2025","journal-title":"Clin. Rheumatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1038\/s41467-018-06672-6","article-title":"Genetic signature to provide robust risk assessment of psoriatic arthritis development in psoriasis patients","volume":"9","author":"Patrick","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"g7594","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): Explanation and elaboration","volume":"162","author":"Moons","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e071018","DOI":"10.1136\/bmj-2022-071018","article-title":"Transparent reporting of multivariable prediction models developed or validated using clustered data: TRIPOD-Cluster checklist","volume":"380","author":"Debray","year":"2023","journal-title":"BMJ"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"m441","DOI":"10.1136\/bmj.m441","article-title":"Calculating the sample size required for developing a clinical prediction model","volume":"368","author":"Riley","year":"2020","journal-title":"BMJ"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/09622802231151220","article-title":"Minimum sample size for developing a multivariable prediction model using multinomial logistic regression","volume":"32","author":"Pate","year":"2023","journal-title":"Stat. Methods Med. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e074819","DOI":"10.1136\/bmj-2023-074819","article-title":"Evaluation of clinical prediction models (part 1): From development to external validation","volume":"384","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jclinepi.2021.02.011","article-title":"External validation of clinical prediction models: Simulation-based sample size calculations were more reliable than rules-of-thumb","volume":"135","author":"Snell","year":"2021","journal-title":"J. Clin. Epidemiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e074821","DOI":"10.1136\/bmj-2023-074821","article-title":"Evaluation of clinical prediction models (part 3): Calculating the sample size required for an external validation study","volume":"384","author":"Riley","year":"2024","journal-title":"BMJ"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"White, N., Parsons, R., Collins, G., and Barnett, A. (2023). Evidence of questionable research practices in clinical prediction models. BMC Med., 21.","DOI":"10.1186\/s12916-023-03048-6"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: Potential and pitfalls","volume":"338","author":"Sterne","year":"2009","journal-title":"BMJ"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/03610918.2013.868906","article-title":"A Goodness of Fit Test for the Multilevel Logistic Model","volume":"45","author":"Perera","year":"2015","journal-title":"Commun. Stat.\u2014Simul. Comput."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e078276","DOI":"10.1136\/bmj-2023-078276","article-title":"Developing clinical prediction models: A step-by-step guide","volume":"386","author":"Efthimiou","year":"2024","journal-title":"BMJ"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity Analysis in Observational Research: Introducing the E-Value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","article-title":"Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators","volume":"74","author":"Calster","year":"2018","journal-title":"Eur. Urol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1007\/s00296-024-05722-1","article-title":"Biological therapy for psoriatic arthritis: Current state and future perspectives","volume":"44","author":"Boboryko","year":"2024","journal-title":"Rheumatol. Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e004314","DOI":"10.1136\/rmdopen-2024-004314","article-title":"Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: Exploring the subclinical psoriatic arthritis stage","volume":"10","author":"Zabotti","year":"2024","journal-title":"RMD Open"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/ard-2023-224148","article-title":"EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis","volume":"82","author":"Zabotti","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/BOR.0b013e32832c6ab9","article-title":"The pathogenesis of psoriatic arthritis and associated nail disease: Not autoimmune after all?","volume":"21","author":"McGonagle","year":"2009","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/rheumatology\/keaa692","article-title":"Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: Results from a national register-based cohort study","volume":"60","author":"Bengtsson","year":"2021","journal-title":"Rheumatology"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Fratton, Z., Giovannini, I., Zabotti, A., and Errichetti, E. (2024). Skin and Nail Predictors of Psoriatic Arthritis Development: A Holistic Overview Integrating Epidemiological and Physiopathological Data. J. Clin. Med., 13.","DOI":"10.3390\/jcm13226880"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.42661","article-title":"Derivation of a Multivariable Psoriatic Arthritis Risk Estimation Tool (PRESTO): A Step Towards Prevention","volume":"77","author":"Eder","year":"2025","journal-title":"Arthritis Rheumatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3899\/jrheum.2024-0266","article-title":"GRAPPA 2023: Major Projects, Key Advances, and Milestones","volume":"51","author":"Ayan","year":"2024","journal-title":"J. Rheumatol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6215\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T10:53:37Z","timestamp":1786445617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":40,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15166215"],"URL":"https:\/\/doi.org\/10.3390\/jcm15166215","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}